Uniform Suspension of the Clustered Triamcinolone Acetonide Particle
Purpose. MaQaid (MaQ) is a new triamcinolone acetonide commercialised in Japan to visualize the vitreous. Because MaQ is preservative-free, it has a lower risk of ocular toxicities. However, since MaQ is only available as a powder, it needs suspenssion. Suspension does not always result uniformally,...
Saved in:
| Main Authors: | Masahiko Sugimoto, Mineo Kondo, Masayuki Horiguchi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2013/315658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dermatofibrosarcoma protuberans
misdiagnosed as keloid and treated with
triamcinolone acetonide
by: Erick Horta Portugal, et al.
Published: (2016-03-01) -
Multifunctional Triamcinolone Acetonide Microneedle Patches for Atopic Dermatitis Treatment
by: Liwan Song, et al.
Published: (2024-12-01) -
Jet Stream Injury From Triamcinolone Acetonide Leading To Perifoveal Tear
by: Manabjyoti Barman, et al.
Published: (2021-01-01) -
Efficacy of intraoperative subconjunctival triamcinolone acetonide as antifibrotic agent in filtration surgery
by: Krishlex G. Gruezo, MD, et al.
Published: (2007-12-01) -
A Comparison of Intralesional Triamcinolone Acetonide Injection for Primary Chalazion in Children and Adults
by: Jacky W. Y. Lee, et al.
Published: (2014-01-01)